ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
Diabetic nephropathy (DN) is one of the main causes of renal fibrosis and is associated with high morbidity and mortality. Traditional Chinese Medicine (TCM) therapy has a long history of usage in a clinical setting and its usage is increasing. ErHuang Formula (EHF), a Chinese herbal compound, has b...
Main Authors: | Yu-Li Shen, Yi-ping Jiang, Xiao-Qin Li, Su-Juan Wang, Ming-Hua Ma, Chun-Yan Zhang, Jian-Yong Zhu, Khalid Rahman, Li-Jun Zhang, Xin Luan, Hong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01596/full |
Similar Items
-
RETRACTED: Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
by: Yu-Li Shen, et al.
Published: (2021-11-01) -
JAK/STAT in leukemia: a clinical update
by: Dong Liang, et al.
Published: (2024-01-01) -
Attribution and identification of absorbed components by HPLC-DAD-ESI-MS after oral administration of Erhuang decoction
by: Jinglong Wang, et al.
Published: (2020-08-01) -
Delamanid suppresses CXCL10 expression via regulation of JAK/STAT1 signaling and correlates with reduced inflammation in tuberculosis patients
by: Min Qiao, et al.
Published: (2022-11-01) -
Retraction: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01)